-
Rapid Insulin
Insulin Lispro, Aspart, Glulisine
-
Short/Regular Insulin
Humulin R, Novolin R
-
Intermediate Insulin
Humulin N, Novolin N
-
Long Acting Insulin
Insulin Glargine, Degludec, Detemir
-
Sulfonylureas Short acting
Tobutamide, Glipizide, Tolazamide
-
Sulfonylureas Long Acting
Glyburide, Chlorpropamide, Glimepiride
-
Glinides
Nateglinide, Rapeglinide
-
-
-
Alpha-Glusidase Inhibitors
Acarbose, Miglitol
-
Incretin Mimetics - Short Acting
Exenatide, Lixisenatide
-
Incretin Mimetics - Long Acting
Liraglutide
-
DPP-4 Inhibitors
-Gliptin
-
SGLT-2 Inhibitors
-Gliflozin
-
Drugs that lead to weight gain
Sulfonylureas and TZDs
-
Drugs that help with weight loss
Incretin mimetics (liraglutide) and SGLT-2 Inhibitors (-gliflozin)
-
Risk of Hypoglycemia
Sulfonylureas
-
Risk of Euglycemic DKA
SGLT-2 Inhibitors (-gliflozin)
-
Not to be used with renal dysfunction
Alpha-Glucosidase inhibtors, Incretin mimetics, and SGLT-2 inhibitors
|
|
